🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether it is possible to predict...
Status
Terminated
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Start Date
2011-05
Trial ID
NCT01855061
Treatments Being Tested
RATIONALE: Studying samples of blood, tissue, and bone marrow from patients...
Status
Completed
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT01511575
Treatments Being Tested
RATIONALE: Riluzole may stop or slow the growth of tumor cells and may be a...
Status
Terminated
Location
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
Start Date
2007-02
Trial ID
NCT00667901
RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11
Trial ID
NCT00423865
The purpose of the protocol is to describe the distribution of IGF-1 defici...
Status
Completed
Location
Ipsen Central Contact
Start Date
2008-10
Trial ID
NCT00710307
Treatments Being Tested
RATIONALE: Studying samples of blood and/or tissue in the laboratory from p...
Status
Completed
Location
Addenbrooke's Hospital
Start Date
2007-07
Trial ID
NCT00900536
This study evaluates the addition of "Kidney Solid Organ Rejection Test" (k...
Status
Completed
Location
National Institute of Medical Sciences and Health Salvador Zubiran
Start Date
2014-09
Trial ID
NCT02581436
Treatments Being Tested
Cerebrovascular accidents (CVA) are the second leading cause of death in Fr...
Status
Terminated
Location
Chu Dijon Bourgogne
Start Date
2022-02-14
Trial ID
NCT05190510
The next generation of personalized medical treatment according to the type...
Status
Unknown
Location
Samsung Medical Center
Start Date
2013-11
Trial ID
NCT02299622
Treatments Being Tested
Recent studies estimate that the prevalence of pituitary adenomas is approx...
Status
Completed
Location
Hospices Civils de Lyon - Groupement Hospitalier Est
Start Date
2013-09
Trial ID
NCT01903967